These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17939560)

  • 21. Diagnostic imaging findings and endocrine test results in dogs with pituitary-dependent hyperadrenocorticism that did or did not have neurologic abnormalities: 157 cases (1989-2005).
    Wood FD; Pollard RE; Uerling MR; Feldman EC
    J Am Vet Med Assoc; 2007 Oct; 231(7):1081-5. PubMed ID: 17916035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of pituitary tumor irradiation in cats.
    Mayer MN; Greco DS; LaRue SM
    J Vet Intern Med; 2006; 20(5):1151-4. PubMed ID: 17063708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenocorticism.
    Bertoy EH; Feldman EC; Nelson RW; Dublin AB; Reid MH; Feldman MS
    J Am Vet Med Assoc; 1996 Apr; 208(8):1268-73. PubMed ID: 8635969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and outcome in 15 dogs treated with transsphenoidal hypophysectomy for nonfunctional sellar masses.
    Hyde BR; Martin LG; Chen AV; Guess SC; Carrera-Justiz S; Bruyette D; Owen TJ
    Vet Surg; 2023 Jan; 52(1):69-80. PubMed ID: 36416123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irradiation of brain tumors in dogs with neurologic disease.
    Bley CR; Sumova A; Roos M; Kaser-Hotz B
    J Vet Intern Med; 2005; 19(6):849-54. PubMed ID: 16355679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of cobalt 60 radiotherapy in dogs with pituitary-dependent hyperadrenocorticism.
    Goossens MM; Feldman EC; Theon AP; Koblik PD
    J Am Vet Med Assoc; 1998 Feb; 212(3):374-6. PubMed ID: 9470046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary chromophobe carcinoma with a low level of serum gonadotropin and an aspermatogenesis in a dog.
    Sato J; Sato R; Kinai M; Tomizawa N; Osawa T; Nakada K; Yano A; Goryo M; Naito Y
    J Vet Med Sci; 2001 Feb; 63(2):183-5. PubMed ID: 11258457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging for diagnosis of pituitary macrotumors in dogs.
    Duesberg CA; Feldman EC; Nelson RW; Bertoy EH; Dublin AB; Reid MH
    J Am Vet Med Assoc; 1995 Mar; 206(5):657-62. PubMed ID: 7744687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary macroadenomas and macroadenocarcinomas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986).
    Nelson RW; Ihle SL; Feldman EC
    J Am Vet Med Assoc; 1989 Jun; 194(11):1612-7. PubMed ID: 2753785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Definitive-intent uniform megavoltage fractioned radiotherapy protocol for presumed canine intracranial gliomas: retrospective analysis of survival and prognostic factors in 38 cases (2013-2019).
    Debreuque M; De Fornel P; David I; Delisle F; Ducerveau MN; Devauchelle P; Thibaud JL
    BMC Vet Res; 2020 Oct; 16(1):412. PubMed ID: 33129320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary corticotroph macrotumors. Diagnosis and treatment.
    Ihle SL
    Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):287-97. PubMed ID: 9076908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Survival Times for Dogs with Pituitary-Dependent Hyperadrenocorticism in a Primary-Care Hospital: Treated with Trilostane versus Untreated.
    Nagata N; Kojima K; Yuki M
    J Vet Intern Med; 2017 Jan; 31(1):22-28. PubMed ID: 27906457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short survival time following palliative-intent hypofractionated radiotherapy for non-resectable canine thyroid carcinoma: A retrospective analysis of 20 dogs.
    Tsimbas K; Turek M; Christensen N; Vail DM; Forrest L
    Vet Radiol Ultrasound; 2019 Jan; 60(1):93-99. PubMed ID: 30180282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity-modulated and image-guided radiation therapy for treatment of genitourinary carcinomas in dogs.
    Nolan MW; Kogan L; Griffin LR; Custis JT; Harmon JF; Biller BJ; Larue SM
    J Vet Intern Med; 2012; 26(4):987-95. PubMed ID: 22624845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of a novel, moderately hypofractionated radiation protocol in 56 dogs with symptomatic intracranial neoplasia.
    Schwarz P; Meier V; Soukup A; Drees R; Besserer J; Beckmann K; Roos M; Rohrer Bley C
    J Vet Intern Med; 2018 Nov; 32(6):2013-2020. PubMed ID: 30308086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation therapy for pituitary tumors in the dog and cat.
    Mayer MN; Treuil PL
    Can Vet J; 2007 Mar; 48(3):316-8. PubMed ID: 17436912
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors.
    Glasser SA; Charney S; Dervisis NG; Witten MR; Ettinger S; Berg J; Joseph R
    J Am Anim Hosp Assoc; 2014; 50(2):96-104. PubMed ID: 24446402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete surgical removal of a very enlarged pituitary corticotroph adenoma in a dog.
    Fracassi F; Mandrioli L; Shehdula D; Diana A; Grinwis GC; Meij BP
    J Am Anim Hosp Assoc; 2014; 50(3):192-7. PubMed ID: 24659728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. X-ray phototherapy for canine brain masses.
    Norman A; Ingram M; Skillen RG; Freshwater DB; Iwamoto KS; Solberg T
    Radiat Oncol Investig; 1997; 5(1):8-14. PubMed ID: 9303051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of diagnostic computerized tomography and radiation therapy in canine and feline hyperadrenocorticism.
    Mauldin GN; Burk RL
    Probl Vet Med; 1990 Dec; 2(4):557-64. PubMed ID: 2134074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.